Cargando…

Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study

BACKGROUND: Coronary accessibility following redo–transcatheter aortic valve replacement (redo-TAVR) is increasingly important, particularly in younger low-risk patients. This study aimed to predict coronary accessibility after simulated Sapien-3 balloon-expandable valve implantation within an Evolu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Gilbert H.L., Spencer, Julianne, Rogers, Toby, Grubb, Kendra J., Gleason, Patrick, Gada, Hemal, Mahoney, Paul, Dauerman, Harold L., Forrest, John K., Reardon, Michael J., Blanke, Philipp, Leipsic, Jonathon A., Abdel-Wahab, Mohamed, Attizzani, Guilherme F., Puri, Rishi, Caskey, Michael, Chung, Christine J., Chen, Ying-Hwa, Dudek, Dariusz, Allen, Keith B., Chhatriwalla, Adnan K., Htun, Wah Wah, Blackman, Daniel J., Tarantini, Giuseppe, Zhingre Sanchez, Jorge, Schwartz, Greta, Popma, Jeffrey J., Sathananthan, Janarthanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653288/
https://www.ncbi.nlm.nih.gov/pubmed/37988439
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.123.013238
Descripción
Sumario:BACKGROUND: Coronary accessibility following redo–transcatheter aortic valve replacement (redo-TAVR) is increasingly important, particularly in younger low-risk patients. This study aimed to predict coronary accessibility after simulated Sapien-3 balloon-expandable valve implantation within an Evolut supra-annular, self-expanding valve using pre-TAVR computed tomography (CT) imaging. METHODS: A total of 219 pre-TAVR CT scans from the Evolut Low-Risk CT substudy were analyzed. Virtual Evolut and Sapien-3 valves were sized using CT-based diameters. Two initial Evolut implant depths were analyzed, 3 and 5 mm. Coronary accessibility was evaluated for 2 Sapien-3 in Evolut implant positions: Sapien-3 outflow at Evolut node 4 and Evolut node 5. RESULTS: With a 3-mm initial Evolut implant depth, suitable coronary access was predicted in 84% of patients with the Sapien-3 outflow at Evolut node 4, and in 31% of cases with the Sapien-3 outflow at Evolut node 5 (P<0.001). Coronary accessibility improved with a 5-mm Evolut implant depth: 97% at node 4 and 65% at node 5 (P<0.001). When comparing 3- to 5-mm Evolut implant depth, sinus sequestration was the lowest with Sapien-3 outflow at Evolut node 4 (13% versus 2%; P<0.001), and the highest at Evolut node 5 (61% versus 32%; P<0.001). CONCLUSIONS: Coronary accessibility after Sapien-3 in Evolut redo-TAVR relates to the initial Evolut implant depth, the Sapien-3 outflow position within the Evolut, and the native annular anatomy. This CT-based quantitative analysis may provide useful information to inform and refine individualized preprocedural CT planning of the initial TAVR and guide lifetime management for future coronary access after redo-TAVR. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02701283.